| 发明名称 |
PYRROLIDINE FUSED INDOLOBENZADIAZEPINE HCV NS5B INHIBITORS |
| 摘要 |
<p>The disclosure provides compounds of formula I, including their salts, as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV.</p> |
| 申请公布号 |
EP2280978(B1) |
申请公布日期 |
2013.04.24 |
| 申请号 |
EP20090724429 |
申请日期 |
2009.03.25 |
| 申请人 |
BRISTOL-MYERS SQUIBB COMPANY |
发明人 |
YANG, ZHONG;BENDER, JOHN, A.;KADOW, JOHN, F. |
| 分类号 |
C07D487/14;A61K31/55;A61P31/12 |
主分类号 |
C07D487/14 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
